Gene · 2073
Papers2,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ribosomal Dysfunction Is a Common Pathomechanism in Different Forms of Trichothiodystrophy. | Cells | 2023 | 37508541 | PubTator, text mining | PubMed |
| Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. | Front Oncol | 2023 | 37492478 | PubTator, text mining | PubMed |
| ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. | EMBO Mol Med | 2023 | 37491889 | PubTator, text mining | PubMed |
| Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination. | Nucleic Acids Res | 2023 | 37470997 | PubTator, text mining | PubMed |
| Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis. | Front Oncol | 2023 | 37456262 | PubTator, text mining | PubMed |
| Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers. | NAR Cancer | 2023 | 37435531 | PubTator, text mining | PubMed |
| Sarcomatoid Carcinoma of Orbit in a Patient With Xeroderma Pigmentosum. | J Med Cases | 2023 | 37435110 | PubTator, text mining | PubMed |
| Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1. | Mol Oncol | 2023 | 37408496 | PubTator, text mining | PubMed |
| ASH1L-MRG15 methyltransferase deposits H3K4me3 and FACT for damage verification in nucleotide excision repair. | Nat Commun | 2023 | 37393406 | PubTator, text mining | PubMed |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. | Cancer Med | 2023 | 37387515 | PubTator, text mining | PubMed |
| Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer. | JCO Precis Oncol | 2023 | 37384868 | PubTator, text mining | PubMed |
| A Protein Asteroid with PIN Domain in Silkworm Bombyx mori Is Involved in Anti-BmNPV Infection. | Insects | 2023 | 37367365 | PubTator, text mining | PubMed |
| Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. | Proc Natl Acad Sci U S A | 2023 | 37364129 | PubTator, text mining | PubMed |
| The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies. | Cancers (Basel) | 2023 | 37345043 | PubTator, text mining | PubMed |
| The role of aging and brain-derived neurotrophic factor signaling in expression of base excision repair genes in the human brain. | Aging Cell | 2023 | 37334527 | PubTator, text mining | PubMed |
| Comparison of the morphological characteristics of the choroidal sublayer between idiopathic macular holes and epiretinal membranes with automatic analysis. | BMC Ophthalmol | 2023 | 37328791 | PubTator, text mining | PubMed |
| NKAP acts with HDAC3 to prevent R-loop associated genome instability. | Cell Death Differ | 2023 | 37322264 | PubTator, text mining | PubMed |
| Dissection of DNA damage and repair pathways in live cells by femtosecond laser microirradiation and free-electron modeling. | Proc Natl Acad Sci U S A | 2023 | 37307476 | PubTator, text mining | PubMed |
| The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer. | Front Cell Dev Biol | 2023 | 37305685 | PubTator, text mining | PubMed |
| A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21. | J Biol Chem | 2023 | 37301510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2073/papers?page=9